Ajanta Pharma Launches Met XL AMT 25 mg a triple FDC for Uncontrolled Hypertension with CAD Deeksha Bhandari20 Jun 2025 12:00 PM ISTIn a first move Ajanta pharma one of the leaders in the cardiology segment, has announced the launch of Met XL AMT 25 mg. It is a triple-drug...
FDA Approves First Triple-Drug Polypill for Initial Hypertension Treatment Dr. Kamal Kant Kohli13 Jun 2025 9:15 AM ISTThe FDA has approved Widaplik, a polypill combining telmisartan, amlodipine, and indapamide, for the treatment of hypertension in adults, including as...
Alembic Pharma bags USFDA nod for high BP traetment drug Ruchika Sharma23 May 2025 3:29 PM ISTVadodara: Alembic Pharmaceuticals Limited has received final approval from the US Food & Drug Administration (USFDA) for Amlodipine...
Court Restrains Medreich from Using Jubilant's Losartan, Amlodipine, Citalopram Dossiers Farhat Nasim7 March 2025 6:44 PM ISTNoida: In relief to Jubilant Generics Ltd, the Commercial Court No. II, Gautam Buddh Nagar, has granted a temporary injunction against Medreich...
Exemed Pharmaceutical Gets CDSCO Panel Nod To Manufacture, Market Amlodipine, Bisoprolol FDC Dr. Divya Colin28 Dec 2024 6:00 PM ISTNew Delhi: Considering the request for bioequivalence (BE) and Phase III clinical trial (CT) waiver, the Subject Expert Committee (SEC) functional...
Two-medication combo pills successfully lowers blood pressure among adults in India: Study Dr. Kamal Kant Kohli25 Nov 2024 8:00 PM ISTMedication variations that combined two of three different blood pressure-lowering medications into a single pill worked equally well in reducing...
Misuse of Confidential Drug Dossiers for Losartan, Citalopram, Amlodipine: Noida Court Upholds Jubilant Generics' Injunction Against Rivals Farhat Nasim14 Nov 2024 4:38 PM ISTNoida: A commercial court in Noida has upheld the injunction in favor of Jubilant Generics, preventing companies from manufacturing and supplying...
Medical Bulletin 03/ September /2024 Dr. Garima Soni3 Sept 2024 3:00 PM ISTHere are the top medical news of the day:Does Continuing Beta-Blockers After a Heart Attack Make a Difference? New Study Sheds Lights New research...
Single-Pill Combination of Four Blood Pressure Medications Outperforms Three-Medication Pill: QUADRO Trial Reveals Dr. Garima Soni3 Sept 2024 8:30 AM ISTNew research presented at ESC Congress 2024 reveals that a single pill combining four blood pressure-lowering medications is significantly more...
Drug Safety Alert: Indian Pharmacopoeia Commission Flags ADR Linked To amlodipine and acetazolamide Susmita Roy4 July 2024 6:00 PM ISTNew Delhi: The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of June, has revealed adverse drug...
CDSCO declares 5 formulations as spurious: Details Dr. Divya Colin17 Jun 2024 6:00 PM ISTNew Delhi: In the latest spurious drug alert, the apex drug regulatory body, the Central Drug Standard Control Organization (CDSCO), has declared 5...
Systolic BP Variability powerful determinant of CV outcome; amlodipine may render long-term benefit: confirms ASCOT trial Medha Baranwal18 Feb 2024 5:30 PM ISTUK: Systolic blood pressure variability (SBPV) is a strong predictor of cardiovascular (CV) outcomes, even in those with controlled systolic blood...
